Table 3.
Group | VAS | |||
---|---|---|---|---|
| ||||
Before treatment | After treatment | t | P | |
Study Group B (n=40) | 6.30±1.18 | 1.85±1.27 | 24.881 | < 0.001 |
Study Group A (n=40) | 6.75±1.56 | 3.25±1.30 | 18.812 | < 0.001 |
t | 415.657 | 4.876 | ||
P | < 0.001 | < 0.001 |
Note: VAS: Pain score.
Group | VAS | |||
---|---|---|---|---|
| ||||
Before treatment | After treatment | t | P | |
Study Group B (n=40) | 6.30±1.18 | 1.85±1.27 | 24.881 | < 0.001 |
Study Group A (n=40) | 6.75±1.56 | 3.25±1.30 | 18.812 | < 0.001 |
t | 415.657 | 4.876 | ||
P | < 0.001 | < 0.001 |
Note: VAS: Pain score.